Cancer immunotherapy strategy equips T cells with molecular GPS that lets them home in on brain tumors and sites of ...

The regulator HIF1α functions in a cancer-microenvironment that lacks oxygen, and it may be involved in resistance to immune ...

Cancer cells impair monocyte-mediated T-cell activation by disrupting inflammatory pathways in the tumor microenvironment.

In addition to targeting a specific tumor protein, the treatment includes a bispecific antibody that enhances the therapeutic ...

Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...

The novel link between nutrition and cell identity offers a new explanation for exhausted T cell identity and in turn, offers ...

Beta-hydroxybutyrate (BHB), a ketogenic diet metabolite, enhances CAR T cell activation, offering a cost-effective boost for ...

Fibroblastic reticular cells (FRCs) create T-cell-supportive niches within lung cancer tumors, facilitating T-cell migration, ...

Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across ...

BriaCell reports influx of cancer fighting CD8+ “killer” T cell into metastatic breast cancer tumors and lymph organs turning “Cold” tumors and lymph nodes “Hot” on ImmunoPET imaging in cancer ...